Current perspectives on the use of miRNA as a biomarker for EGFR-targeted therapy for non-small cell lung cancer

Current perspectives on the use of miRNA as a biomarker for EGFR-targeted therapy for non-small cell lung cancer

Non-small cell lung cancer (NSCLC) is the leading cause of death from cancer in the world. Currently, a large number of research studies are conducted to develop and implement new treatment strategies. Intensive efforts are also made to improve the robustness of modern molecular diagnostics to ident...

Full description

Bibliographic Details
Main Authors: Mateusz Florczuk, Adam Szpechciński, Joanna Chorostowska-Wynimko
Format: Article
Language:English
Published: Index Copernicus International S.A. 2017-01-01
Series:Postępy Higieny i Medycyny Doświadczalnej
Subjects:
miRNA
non-small cell lung cancer
biomarkers
targeted therapy
EGFR tyrosine kinase inhibitors
Online Access:http://phmd.pl/gicid/01.3001.0010.7613

Similar Items

Similar Items